Surface Guided Radiation Therapy (SGRT) Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device Type (Portable and Fixed), By Application (Breast Cancer, Head & Neck Cancer, Abdominal & Pelvic Cancer, Dermatology, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region and Competition, 2020-2030F

Market Overview

Global Surface Guided Radiation Therapy (SGRT) Devices Market was valued at USD 235.56 million in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 10.04% through 2030. The rise in the prevalence of cancer globally is one of the main factors driving the growth of the SGRT (Surface Guided Radiation Therapy) devices market. Advancements in technology have revolutionized radiation therapy by improving treatment accuracy, reducing the time required for treatment sessions, and minimizing damage to healthy tissues. These notable improvements have significantly contributed to the growing demand for SGRT devices.

The future of the SGRT devices market looks highly promising, with continuous innovations and research driving further growth. As healthcare providers increasingly recognize the benefits of SGRT technology, its adoption is projected to expand. Additionally, as patients become more aware of the advantages associated with SGRT, the demand for these devices is expected to soar.

Key Market Drivers

Rise in Prevalence of Cancer

Cancer, one of the leading causes of death globally, continues to affect millions of individuals each year. Increasing incidence of cancer has led to a growing demand for innovative and effective treatment modalities, such as Surface Guided Radiation Therapy (SGRT).

SGRT devices offer a highly precise and non-invasive form of radiotherapy that minimizes damage to healthy tissues surrounding tumors. By utilizing advanced imaging and tracking technologies, SGRT enables real-time patient monitoring and movement tracking during radiation treatment. This level of precision and accuracy allows healthcare professionals to deliver precise radiation doses to the tumor while sparing healthy tissues, particularly beneficial in treating cancers located near critical organs.

The rising number of cancer cases and the need for more targeted and personalized treatments have driven the growth of the SGRT devices market. With ongoing research and technological advancements, SGRT devices have become an integral part of modern cancer treatment strategies. The ability to deliver radiation therapy with enhanced precision and efficiency has significantly improved patient outcomes and quality of life.

In conclusion, the rise in the prevalence of cancer is a major driver of the global SGRT devices market. As the demand for effective cancer treatments continues to grow, the need for advanced technologies like SGRT will only become more critical. With ongoing research and development, the SGRT devices market is poised for significant growth in the coming years, offering new hope and improved outcomes for cancer patients worldwide.

Rise in Healthcare Expenditure

A significant portion of healthcare expenditure is allocated towards investing in advanced technologies like Surface Guided Radiation Therapy (SGRT). As healthcare providers actively seek to offer more effective treatments and improve patient outcomes, the demand for innovative and precise treatment modalities such as SGRT has witnessed a remarkable surge.

SGRT devices provide a highly accurate form of radiotherapy that minimizes damage to healthy tissues surrounding tumors. This cutting-edge technology utilizes real-time imaging and tracking to ensure precise delivery of radiation, improving treatment efficiency and reducing potential side effects. With the increase in healthcare spending, hospitals and cancer research institutes are now able to afford and invest in these high-end devices, consequently driving the growth of the SGRT devices market.

The continuous advancements in radiation therapy technologies, including the integration of artificial intelligence and machine learning algorithms, further enhance the capabilities of SGRT devices. This, along with the increasing adoption of SGRT devices across hospitals and cancer research institutes, is expected to contribute significantly to the market growth.

The rise in healthcare expenditure plays a pivotal role in driving the global SGRT devices market. As healthcare spending continues to grow, the demand for advanced technologies like SGRT will become even more critical. With ongoing research, technological advancements, and the integration of intelligent algorithms, the SGRT devices market is poised for significant growth in the coming years, revolutionizing the field of radiation therapy and improving patient care.

Download Free Sample Report

Key Market Challenges

Limited Awareness and Adoption of SGRT Devices

Despite the proven effectiveness of Surface Guided Radiation Therapy (SGRT) devices in enhancing the precision and accuracy of radiation therapy, there is still a significant lack of awareness and understanding among healthcare professionals and patients regarding this advanced technology. This lack of awareness can primarily be attributed to various factors.

The relatively recent introduction of SGRT devices has limited their widespread adoption and knowledge. Traditional radiation therapy methods have been dominant for a long time, and it takes time for new technologies to gain recognition and acceptance in the medical field.

The complexity of SGRT devices and the need for specialized training to operate them further contribute to the limited awareness and understanding among healthcare providers. The technical aspects and intricacies of SGRT devices require healthcare professionals to undergo specific training to ensure proper utilization and maximize the benefits of this technology.

The limited awareness directly impacts the adoption rate of SGRT devices, not only in developing countries with resource constraints but also in developed countries. Many hospitals and cancer research institutes, particularly those in resource-limited settings, still heavily rely on conventional radiation therapy methods due to the high cost associated with implementing and maintaining SGRT devices.

The need for specialized training and technical expertise to operate SGRT devices can pose challenges to their widespread adoption, especially in regions facing shortages of skilled healthcare professionals. The scarcity of trained personnel capable of operating and maintaining SGRT devices can hinder the integration and utilization of this advanced technology in healthcare facilities.

Despite the proven effectiveness of SGRT devices, the lack of awareness, the dominance of traditional methods, the complexity of the technology, and the need for specialized training and resources all contribute to the limited adoption and understanding of SGRT devices in the field of radiation therapy.

Key Market Trends

Growing Focus on Personalized Medicine

Personalized medicine, also known as precision medicine, is a revolutionary approach that seeks to optimize medical treatment based on the unique characteristics of each patient. By leveraging genetic or other biomarker information, healthcare providers can tailor preventative health care plans and therapies to the individual needs of patients.

In recent years, personalized medicine has gained significant traction in the healthcare industry, driven by remarkable advancements in genomics, proteomics, and metabolomics, as well as the development of targeted therapies. This paradigm shift towards personalized medicine has had a profound impact on the market for Surface Guided Radiation Therapy (SGRT) devices.

SGRT devices offer an unparalleled level of precision in radiotherapy, which plays a crucial role in the personalized treatment of cancer patients. By utilizing real-time imaging and monitoring, these devices empower healthcare professionals to administer radiation doses that are precisely tailored to the dimensions and location of a patient's tumor. This targeted approach minimizes the potential damage to surrounding healthy tissues, enhancing the overall efficacy and safety of radiation therapy.

As the healthcare industry increasingly embraces personalized medicine, there has been a surge in the demand for SGRT devices. These innovative technologies enable the delivery of individualized and targeted radiation therapy, aligning with the growing need for more precise and effective treatment options. With the rise of personalized medicine, SGRT devices have become an indispensable tool in the arsenal of healthcare professionals, revolutionizing the way cancer patients receive tailored and optimized radiation therapy.

Segmental Insights

Device Type Insights

Based on the category of device type, the fixed segment emerged as the dominant player in the global market for Surface Guided Radiation Therapy (SGRT) Devices in 2024. Fixed SGRT devices have greatly benefited from recent technological advancements, revolutionizing the field of radiation therapy. These devices not only incorporate state-of-the-art imaging technologies but also utilize advanced algorithms and machine learning capabilities. This combination enables real-time visualization of the patient's surface during treatment, ensuring precise and accurate delivery of radiation. The high-tech features of fixed SGRT devices have made them the preferred choice in numerous healthcare settings, solidifying their dominance in the market.

Fixed SGRT devices offer an unparalleled level of precision in treating cancerous tumors. By leveraging sophisticated imaging and monitoring systems, these devices can precisely deliver radiation doses that are meticulously tailored to the exact dimensions and characteristics of a patient's tumor. This personalized approach ensures that healthy tissues are spared while targeting cancer cells with exceptional accuracy. The ability to provide such personalized and precise treatment is a significant driving force behind the widespread adoption of fixed SGRT devices in the medical community.

Application Insights

The breast cancer segment is projected to experience rapid growth during the forecast period. Breast cancer is the most common cancer among women worldwide, contributing significantly to the overall global cancer burden. This high incidence rate has led to an increased demand for effective treatment modalities like Surface Guided Radiation Therapy (SGRT). SGRT offers a highly precise form of radiotherapy, leveraging advanced imaging technology to ensure accurate delivery of radiation doses tailored to the exact dimensions and location of a patient's tumor. This level of precision not only maximizes the effectiveness of treatment but also minimizes damage to surrounding healthy tissues, resulting in improved patient outcomes.

SGRT has emerged as a preferred choice for breast cancer treatment due to its exceptional precision and potential for improved outcomes. By utilizing real-time imaging during treatment, SGRT allows healthcare professionals to continuously monitor and adjust radiation delivery based on any patient or tumor movement. This dynamic approach ensures that the radiation is consistently targeted at the tumor, enhancing treatment efficacy while minimizing the risk of unnecessary exposure to healthy tissues. The integration of SGRT into breast cancer treatment has revolutionized the field, offering a precise and personalized approach that optimizes therapeutic benefits.

Furthermore, the utilization of deep inspiration breath-hold (DIBH) techniques in SGRT for breast cancer treatment has further enhanced its dominance in this segment. By instructing patients to hold their breath in a deep inspiration phase during radiation delivery, DIBH techniques effectively increase the distance between the heart and the breast. This reduction in proximity significantly decreases the amount of radiation that reaches the heart, subsequently reducing the risk of heart damage during left-sided breast cancer radiation therapy. The combination of DIBH techniques with the precision of SGRT devices not only improves the safety of treatment but also enhances its overall effectiveness.

Download Free Sample Report

Regional Insights

Europe emerged as the dominant player in the Global Surface Guided Radiation Therapy (SGRT) Devices Market in 2024, holding the largest market share in terms of value. Europe is renowned for its exceptional healthcare systems, which are globally recognized for their cutting-edge technologies and highly skilled healthcare professionals. The advanced infrastructure present in Europe enables the swift adoption and integration of innovative medical devices like SGRT, further solidifying Europe's dominance in the healthcare market.

Moreover, Europe experiences a relatively high incidence rate of cancer, particularly with breast cancer being the most prevalent type among women. This alarming prevalence has resulted in an ever-growing demand for effective treatment methods, such as SGRT, which offers promising outcomes.

One of the key reasons behind Europe's success in the healthcare field is its strong emphasis on research and development. Significant investments are continually being made to develop new and improved treatment methods. This unwavering focus on innovation has led to remarkable advancements in SGRT technology, bolstering Europe's position from as a frontrunner in the healthcare market and serving as a testament to its commitment to providing cutting-edge healthcare solutions.

Recent Development

• In June 2021, C-RAD strengthened its position in India by opening an office in Delhi. This has been done in order to meet the growing demand and strengthen their products positioning in the South Asia region.

• In 2025, Accuray Incorporated launched its VitalHold solution in Japan, aimed at enhancing patient positioning accuracy in radiation therapy. The VitalHold system supports superior immobilization during treatment, helping reduce motion and improve clinical outcomes. This launch aligns with Accuray’s strategic expansion in the Asia-Pacific region, targeting advancements in cancer care through innovative technologies. The VitalHold solution integrates seamlessly with existing radiotherapy platforms, emphasizing precision and patient comfort. This development reflects Accuray’s commitment to addressing growing oncology demands in Japan, further solidifying its presence in the competitive radiation oncology market.

• In 2025, Kerala’s Regional Cancer Centre (RCC) adopted Surface Guided Radiation Therapy (SGRT), marking a significant step forward in patient care. SGRT enables real-time tracking of patient movement during radiation treatment, enhancing accuracy without invasive markers. This technology supports non-invasive, tattoo-free radiotherapy, improving patient comfort and treatment precision. The integration of SGRT at RCC underscores Kerala’s growing role in pioneering advanced cancer treatment technologies in India. It aligns with the center’s mission to provide cutting-edge oncology services, emphasizing safety and personalized care for patients.

• RaySearch Laboratories partnered with Vision RT in 2025 to present advancements in surface-guided treatment planning at the ESTRO conference. Their joint innovations focus on integrating SGRT into radiation therapy workflows, enhancing real-time patient monitoring and adaptive treatment planning. These technologies aim to improve clinical outcomes by minimizing setup errors and patient movement during radiotherapy. The collaboration highlights the growing importance of precision and safety in cancer treatment, reflecting a broader industry trend toward non-invasive, patient-friendly radiation therapy methods. ESTRO 2025 provided a global platform for showcasing these cutting-edge solutions.

• In 2025, Bass Cancer Center earned recognition as a Center of Excellence for delivering safe, accurate radiation therapy without relying on tattoos or permanent marks. Utilizing advanced surface-guided radiation therapy (SGRT), the center prioritizes patient comfort and precision. This distinction reflects the center’s leadership in adopting innovative, patient-centric approaches in oncology. The tattoo-free technique reduces patient anxiety and enhances treatment accuracy by leveraging advanced imaging and tracking technology. This achievement positions Bass Cancer Center as a pioneer in evolving radiotherapy practices in the United States, setting a benchmark for other institutions.

• Kerala continues to advance its cancer care capabilities with new technological implementations and government support in 2025. The state has witnessed enhancements in radiotherapy infrastructure, including the adoption of SGRT and increased access to cutting-edge treatments. Government initiatives have strengthened oncology services, focusing on improving patient outcomes and accessibility. These developments align with Kerala’s broader healthcare strategy to combat rising cancer incidence through modern technology and expert care. The synergy between government programs and cancer centers fosters an environment conducive to innovation, ultimately benefiting patients across the region.

Key Market Players

• Vision RT Ltd.
• C-RAD AB
• Varian Medical Systems Inc
• BrainLab AG
• Klarity Medical
• Mirion Technologies, Inc.
• Elekta AB
• Surface Imaging Solutions Limited
• Civco Medical Instruments Co. Inc.
• Accuray Inc

Report Scope:

In this report, the Global Surface Guided Radiation Therapy (SGRT) Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type:

o   Portable

o   Fixed

• Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Application:

o   Breast Cancer

o   Head & Neck Cancer

o   Abdominal & Pelvic Cancer

o   Dermatology

o   Others

• Global Surface Guided Radiation Therapy (SGRT) Devices Market, By End User:

o   Hospitals & Clinics

o   Diagnostic Centers

o   Others

• Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Region:

o   North America

o   Europe

o   Asia Pacific

o   South America

o   Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Surface Guided Radiation Therapy (SGRT) Devices Market.

Available Customizations:

Global Surface Guided Radiation Therapy (SGRT) Devices Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Surface Guided Radiation Therapy (SGRT) Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com